Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Organisation › Details

Merck (DE) (Group)

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2017, Merck generated sales of €15.3 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. *

 

Period Start 1668-01-01 established_pre
Products Industry pharmaceutical
  Industry 2 reagents (bio/biochemical)
Person Person Oschmann, Stefan (Merck (DE) 201604– CEO before Executive Board Member since 2011 before MSD)
     
Region Region Darmstadt
  Country Germany
  Street 250 Frankfurter Str.
  City 64293 Darmstadt
  Tel +49-6151-72-0
    Address record changed: 2024-01-05
     
Basic data Employees I: 50,001 to 100,0 (2018-12-31)
  Currency EUR
  Annual sales 14,836,000,000 (sales, net, consolidated (2018) 2018-12-31)
  Profit 3,396,000,000 (2018-12-31)
  Cash 2,170,000,000 (2018-12-31)
     
    * Document for »About Section«: Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt.
     
   
Record changed: 2023-12-30

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top